PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|June 19, 2013
Equipment and Processing Report
- Equipment and Processing Report-06-19-2013
- Volume 0
- Issue 0
June 2013 Editor's Picks: Products from Brabender Pharma and K-Tron
Equipment from Brabender Pharma and K-Tron
Brabender Pharma
Tabletop twin-screw extruder features easy cleaning.
Brabender Pharma’s PTSE 12/36 EC tabletop, 12-mm pharmaceutical twin-screw extruder is suitable for hot-melt extrusion (HME), early formulation development, and preparation of samples for clinical studies. The more compact addition to the company’s product line enhances the ability to address the challenges of HME in feasibility studies. The extruder has a removable barrel liner and a horizontally split barrel to allow quick access and ease of cleaning and sterilization. Two additional openings can be used as downstream feeding or venting ports. Segmented screws can be configured to customer specifications and optional ports can be added on request.
K-Tron
Micro-ingredient feeder has high accuracy for low feedrates.
Articles in this issue
over 13 years ago
Developments in Pharmaceutical Process Modelingover 13 years ago
INTERPHEX Showcases Machine Innovationsover 13 years ago
Evaluating Parenteral Packaging for Glass DelaminationRelated to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.